About Immunic (IMUX)
Immunic, Inc., formerly Vital Therapies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on developing oral therapies for the treatment of chronic inflammatory and autoimmune diseases. The Company is developing three small... Read more
- USD0.85
- USD0.87
- USD0.72
- USD2.11
- -31.00%
- --
- 184.89k
- 2.19M
- 63M
- 0.56
- -38.20%
Stock News
3 hours ago
After a public breakup, Trump/Musk may reportedly be ready to talk. Tesla shares are bouncing.
MarketWatch
3 hours ago
The Toro Co (TTC) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth
Yahoo
6 hours ago
Nike: Moderate Upside Driven By Innovation And Pricing Power
SeekingAlpha
6 hours ago
SS&C Technologies Delivers On Execution - But Can It Deliver On Valuation?
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
